AGTC

Applied Genetic Technologies Corporation - Common Stock

6.5500
USD
-3.11%
6.5500
USD
-3.11%
3.2500 7.5000
52 weeks
52 weeks

Mkt Cap 118.62M

Shares Out 18.11M

new Chat
Send me real-time posts from this site at my email

Applied Genetic Technology Tumbles 32% On Eye Study Problems

On Tuesday, Applied Genetic Technology (AGTC) tumbled 32% after reporting problems with its gene trial in treating patients with a rare eye disorder. The company even reported earnings for the fiscal fourth quarter, and those earnings were mixed. The stock is not being punished for its mixed earnings report. Most pharmaceutical companies in the clinical stage of testing don't generate revenue, therefore investors are more concerned about the trials themselves.

This is where the fall of 32% in the AGTC stock comes in. The reason for the fall is that there were a few problems with the clinical trials that the company is...


More